A 52-week Post-marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)

CompletedOBSERVATIONAL

Enrollment

1,794

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

HypercholesterolemiaFamilial HypercholesterolemiaHomozygous Sitosterolemia

Interventions

DRUG

Ezetimibe

Ezetimibe, 10-mg tablets,

DRUG

Ezetimibe + other lipid-lowering medication(s)

Ezetimibe, 10-mg tablets, other lipid-lowering medication(s) as prescribed by attending physician